Litcius/Paper detail

Ruthenium(II)–Tris-pyrazolylmethane Complexes Inhibit Cancer Cell Growth by Disrupting Mitochondrial Calcium Homeostasis

Jakub Červinka, Alberto Gobbo, Lorenzo Biancalana, Lenka Marková, Vojtěch Novohradský, Massimo Guelfi, Stefano Zacchini, Jana Kašpárková, Viktor Brabec, Fabio Marchetti

2022Journal of Medicinal Chemistry58 citationsDOIOpen Access PDF

Abstract

and significant selectivity toward cancer cells. The tested compounds effectively accumulate in cancer cells, and mitochondria represent a significant target of biological action. Most notably, data provide convincing evidence that the mechanism of biological action is mediated by the inhibiting of mitochondrial calcium intake.

Topics & Concepts

ChemistryTrisCalciumRutheniumMitochondrionHomeostasisCell growthCell biologyBiochemistryCatalysisOrganic chemistryBiologyMetal complexes synthesis and propertiesClick Chemistry and ApplicationsFerrocene Chemistry and Applications
Ruthenium(II)–Tris-pyrazolylmethane Complexes Inhibit Cancer Cell Growth by Disrupting Mitochondrial Calcium Homeostasis | Litcius